Glaucoma remains the primary cause of irreversible visual impairment on a global scale, often referred to as a silent thief of sight. Because the condition typically progresses without noticeable symptoms for several years, a significant number of patients only receive a diagnosis after the optic nerve has sustained permanent damage.
The Power of Genetic Screening
Recent scientific advancements suggest that leveraging genetic information could revolutionize how we approach this disease. By identifying specific genetic markers, healthcare providers may soon be able to predict not only who is at risk of developing glaucoma but also how rapidly the disease will progress.
Preventing Permanent Vision Loss
The shift toward targeted screening based on genetic profiles offers a path to earlier intervention. Detecting the condition in its nascent stages allows for medical treatments that can halt or slow nerve damage, effectively preserving vision for millions of at-risk individuals worldwide.
